AstraZeneca
AZN
#49
Rank
S$365.90 B
Marketcap
S$118.01
Share price
0.19%
Change (1 day)
25.16%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): S$3.98

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$3.86. In 2024 the company made an earnings per share (EPS) of S$2.89 an increase over its 2023 EPS that were of S$2.44.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$3.9837.96%
2024S$2.8918.23%
2023S$2.4481.13%
2022S$1.35631.03%
2021S$0.18-88.11%
2020S$1.55136.89%
2019S$0.66-39.41%
2018S$1.08-28.27%
2017S$1.51-14.37%
2016S$1.7624.11%
2015S$1.42127.55%
2014S$0.62-51.96%
2013S$1.30-58.95%
2012S$3.16-32.2%
2011S$4.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.28 243.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.36 142.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$2.19-43.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.25 165.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.10 576.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.71 22.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$13.98 262.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.66 150.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.78-2.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.57 18.48%๐Ÿ‡ฌ๐Ÿ‡ง UK